QuidelOrtho is a pure-play diagnostics company that develops and manufactures technologies for diagnostic testing. Its work spans several technical domains, including immunoassay, molecular testing, point-of-care diagnostics, clinical laboratory testing, and transfusion medicine. The company operates on a global scale, with a collective industry experience of more than 120 years.
The company has a history of introducing pioneering products. It helped pioneer the earliest lateral-flow pregnancy test strips. It also produced the first FDA-approved rapid antigen diagnostic test for influenza and was among the earliest to develop a molecular PCR assay for SARS-CoV-2. These products serve settings ranging from clinical laboratories to point-of-care environments.
